The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2019
Filed:
May. 21, 2014
Applicant:
New Pharma Licence Holdings Limited, Valletta, MT;
Inventors:
Pamela Brown, Reading, GB;
Michael Dawson, Reading, GB;
Mona Simonovic, Reading, GB;
Steven Boakes, Reading, GB;
Esther Duperchy, Reading, GB;
Assignee:
NEW PHARMA LICENCE HOLDINGS LIMITED, Valletta, MT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/62 (2006.01); A61K 31/407 (2006.01); A61K 38/00 (2006.01); A61K 31/427 (2006.01); A61K 31/431 (2006.01); A61K 31/496 (2006.01); A61K 31/575 (2006.01); A61K 31/65 (2006.01); A61K 31/7048 (2006.01); A61K 31/7052 (2006.01); A61K 38/08 (2019.01);
U.S. Cl.
CPC ...
C07K 7/62 (2013.01); A61K 31/407 (2013.01); A61K 31/427 (2013.01); A61K 31/431 (2013.01); A61K 31/496 (2013.01); A61K 31/575 (2013.01); A61K 31/65 (2013.01); A61K 31/7048 (2013.01); A61K 31/7052 (2013.01); A61K 38/08 (2013.01); A61K 38/00 (2013.01);
Abstract
Described are compounds of formula (I) for use in combination treatment with a second active agent, such as rifampicin, for example for treatment of a microbial infection. The compound of formula (I) is a polymyxin compound is: